Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic Agents in Combined Anticancer Therapy

20 Apr 2018

Abstract excerpt

In the last decade, epigenetic drugs (such as inhibitors of DNA methyltransferases and histone deacetylases) have been intensively used for cancer treatment. Their applications have shown high anticancer effectivity and tolerable side effects. However, they are unfortunately not effective in the treatment of some types and phenotypes of cancers. Nevertheless, several studies have demonstrated that problems of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Epigenetics and DNA Methylation
Share to Histone Deacetylase Inhibitors Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29676175
DOI: 10.4155/fmc-2017-0203

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic Agents in Combined Anticancer TherapyPMID 29676175Read ↗

Towards targeted epigenetic therapy of cancer.Semantic proximity Read ↗

Novel epigenetic therapeutic strategies and targets in cancerSemantic proximity Read ↗

Radiosensitizing Potential of Epigenetic Anticancer DrugsSemantic proximity Read ↗

Epigenetic drugs as immunomodulators for combination therapies in solid tumorsSemantic proximity Read ↗

Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiationSemantic proximity Read ↗

DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical applicationSemantic proximity Read ↗

The pharmacoepigenetic paradigm in cancer treatmentSemantic proximity Read ↗

The combination of histone deacetylase inhibitors and radiotherapy: a promising novel approach for cancer treatmentSemantic proximity Read ↗

Enhancing the Anticancer Efficacy of Immunotherapy through Combination with Histone Modification InhibitorsSemantic proximity Read ↗

Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in CancerSemantic proximity Read ↗

Emerging Epigenetic‐Based Nanotechnology for Cancer Therapy: Modulating the Tumor MicroenvironmentSemantic proximity Read ↗

Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinicSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.